Background: Autofl uorescence bronchoscopy (AFB) allows a more sensitive approach to the diagnosis of premalignant and malignant endobronchial lesions than white light bronchoscopy (WLB) can do. Aim: To assess the autofl uorescence bronchoscopy and white light bronchoscopy in diagnosing malignant endobronchial lesions.
Lung cancer is a major medical problem, especially with its high mortality rate. In this regard, early diagnosis is extremely important. With the introduction of the fl exible white light bronchoscopy (WLB) it is possible to take endobronchial biopsies in the visual fi eld of the bronchoscopist to sub-segmental level. The choice of the biopsy site depends on visual information and bronchoscopist experience. Autofl uorescence bronchoscopy (AFB) uses autofl uorescence light which makes premalignant and malignant endobronchial lesion more visible by highlighting them in different colors. It has helped us target biopsy techniques more precisely. Our aim was to compare the performance of these two methods in diagnosing lung cancer by conducting the present retrospective study.
MATERIALS AND METHODS
Evis Lucera (CV-260SL) autofl uorescence imaging system (AFI) (Olympus Medical Systems, Tokyo, Japan) was used in the study. White light mode was used fi rst and then the autofl uorescent mode. Finally, the biopsies were performed according the decision of the bronchoscopist.
The information concerning the performed bronchoscopies and biopsy results was gathered from our hospital information system. The follow-up period was one year; the study included 303 patients: 232 men (76.6%) and 71 women (23.4% ). Mean age of men was 61.38±9.56 years, and of women -63.06±10.231 years. The data were analysed using Excel and SPSS Ver. 21 statistics software package on a MacBook Pro.
The registered parameters were patient's name (initials), age and sex, presence of endobronchial changes, type of endobronchial changes observed during white light bronchoscopy, type of endobronchial changes observed during autofl uorescence bronchoscopy, performed forceps biopsy, performed catheter and brush biopsy, pathology and cytology results.
The study followed a retrospective case-control design.
Analysis of the results was done by statistical analysis of nonparametric data. McNemar's test was used to test the hypothesis that AFB targets the place for biopsy better than WLB. The critical level of signifi cance was α = 0.05. The corresponding null hypothesis is rejected when the p value is less than α. [1] [2] [3] We used a 2×2 data table, identifying the diagnostic values of the methods used to calculate the sensitivity, specifi city and positive and negative predictive values.
RESULTS
To describe and classify the endobronchial changes we used a four-grade visual scale classifying the fi ndings: normal mucosa, abnormal but not suspicious, suspicious for tumor, and tumor. The observed endobronchial changes in the two methods were: WLB -slightly pink mucosa, hyperemia and/ or swelling, infi ltration or suspicion and visible tumor; AFB -green coloured mucosa, dark green to light crimson, crimson with distinct borders, visible tumor. 4, 5 To evaluate the histology and cytology results, we used the WHO recommended scale -changes are classifi ed into 9 types according to the fi ndings. 6 The compilation between these two groups of data is shown in Tables 1 and 2 for histology results, and Tables 5 and 6 for cytology results. Sample obtainment method in Tables 1 and 5 is WLB, while Tables 2 and 6 are AFB.
Two hundred and twenty-two patients had a forceps biopsy. Lung carcinoma was found in 116 patients (38.3%). These patients had invasive carcinoma, microinvasive carcinoma, and carcinoma in situ.
The patients with carcinoma are the same number as in these examined with WLB. The differences are in the assessment of the endobronchial changes.
To compare two type of bronchoscopy using a 2×2 table groups of true positive, true negative, false positive and false negative cases have to be defi ned. True positive changes were these in which the bronchoscopy found a tumor and the biopsy showed a tumor. This means invasive carcinoma, microinvasive carcinoma, and carcinoma in situ. True negative cases were these with negative bronchoscopy and no tumor in the biopsy. False positive cases were those in which bronchoscopy found a tumor, but biopsy was negative. False negative means that the bronchoscopist did not fi nd a tumor but the biopsy did.
We tested two options for a true positive group. Tests were performed using two different defi nitions for a true positive group. In the fi rst one, both suspicious and actual tumorous changes are considered a true positive endoscopic fi ndings. In the second defi nition, only actual tumorous changes are accepted. The WLB and AFB datasets in the histology and cytology tables include results representing both defi nitions.
To examine the relationship between the endobronchial changes and histology fi ndings, a test for nonparametric data is used.
The results from applying McNemar's test are shown in Table 3 . It is evident that in the fi rst variant of distribution, in both WBL and AFB, there is a statistical relationship between the bronchoscopic and morphological results in the diagnostic approach of lung cancer (p<0.0001). The fi rst variant demonstrates that it is better to perform biopsy not only on suspicious changes as well, rather than tumorous ones alone.
The Odds Ratio is signifi cantly higher in AFB 8.333 (95% CI 3.571 -23.784), than 0.128 (95% CI 0.045 -0.299) for WLB.
The diagnostic sensitivity, specifi city and positive and negative predictive values in two tested variants of the results are shown in Table 4 .
In the second variant the sensitivity is higher in AFB (83.62%) versus (78.45%) in WLB. The same is true with the negative predictive value in AFB (81.73%) versus (77.27%) in WLB. The success in fi nding visible cancer is slightly higher with fl uorescence than without it. Additionally, if the test is negative , results are even more reliable, given the same mode of investigation is used.
Cytology results are presented in the same nine grade scale for morphological results and four types endoscopic changes.
Lung carcinoma was diagnosed by cytology in 108 patients which is 35.6% of all participants. This number also includes invasive carcinoma, microinvasive carcinoma and carcinoma in situ.
Here, using cytology biopsies, only 1 carcinoma in situ was found, while histology discovered 3 cases.
To evaluate the relationship between the endobronchial changes and cytology results, the same nonparametric test is used.
The results using McNemar's test are shown in Table 7 . Again, only in the fi rst variant of result distribution, in both WLB and AFB, there is a statistical relationship between bronchoscopic and morphological results in the diagnostic approach of lung cancer. Odds Ratio is 3.800 (95% CI 2.123 -7.227) for AFB against 3.471 (95% CI 1.996 -6.351) for WLB. Best biopsy results are achieved after suspicious and tumorous changes have been examined with AFB.
The diagnostic sensitivity, specifi city and positive and negative predictive values in two tested variants of the cytology results are shown in Table 8 .
The diagnostic sensitivity of the fi rst option of AFB is slightly higher than the same in WBL (86.11% against 84.26%). Other results from tests for specifi city, PPV and NPV support a similar verdict of AFB being advantageous over WLB in the diagnosis of lung cancer with cytological biopsies when suspected and tumor endobronchial cases are used as a target.
DISCUSSION
Autofl uorescence bronchoscopy, as a mode of diagnostic bronchoscopy, is superior to white light bronchoscopy in diagnosing endobronchial lung cancer. Of course, they are still often used together depending on the needs and requirements of the specifi c case.
In this regard the results from statistical analyses rejected the null hypothesis and accepted alternative one.
In histology biopsies group, fi rst variant of testing, p<0.0001. Odds Ratio is higher in the AFB group, 8.333 (95% CI 3.571-23.784) against 0.128 (95% CI 0.045-0.299). Sensitivity is high enough -94.83% and the same applies to both modes. This demonstrates that using the suspected changes for guidance, in addition to the visible malignant ones, yields better results (Tables 3, 4) . This is understandable in the context of the fact that AFB gets better results in diagnosing endobronchial premalignant lesions. 7, 8 Regarding this analysis for cytology fi ndings (Tables 7, 8) , that the same fi rst variant grouping of the results, showed signifi cant relationship between the biopsy place and the positive results (p<0.0001). Here the advantage of AFB comparing WLB is weak -OR 3.800 (95% CI 2.123-7.227) against 3.471 (95% CI 1.996 -6.351). The rejection of the null hypothesis and the acceptance of alternative one is not so obvious. Sensitivity, specifi city, positive predictive value and negative predictive value are slightly higher in AFB group, fi rst variant of testing ( Table 8) .
In literature the sensitivities vary from 44% to 100%. 9, 10 In the two meta-analyses the sensitivity is 90% and 94.7%. 11, 12 In cases of severe dysplasia and malignancy Ueno K et al. showed sensitivity of 94.7% with AFB and 73.7% with WLB. 13 The high sensitivity in our study is 94.83% for AFB and WLB histology and 86.11% for AFB cytology results.
This big differences in sensitivity is due mainly to the defi nition of case positive group. Some of the authors defi ne this as patients with invasive cancer only, while others add preinvasive lesions to it. The premalignant lesions can also be added to this group and this leads to a lowering of the sensitivity again. The second reason is the heterogeneity of the designs of the conducted studies.
The specifi city in our study is between 52.83% in variant 1 of grouping using AFB to 80.19% in variant 2 grouping of histology results. In metaanalysis this results are 56% and 60.9%.
The reported specifi city from different colleagues is from 23%, 26% to 82%, 83.3% and 92%. 4, 7, [14] [15] [16] Actually the specifi city of AFB and WLB is low because these investigations have diffi culties in assessing the difference between benign and premalignant/malignant lesions. 12 We assume our results are consistent with most of the published ones and we believe that our conclusions are credible.
The highest results for sensitivity and specifi city are published by B. Zaric et al. 4 He and his coworkers use the same system, as ours -autofl uorescence imaging system (AFI), (Olympus Medical System Corp., Tokyo, Japan).
Other authors that use the same system are TW Jang, F Herth, EJ Cetti and M Chiyo. 7, [16] [17] [18] This system is likely one of the best suited currently available, because AFI displays a light green image for normal epithelium and magenta for an abnormal fl uorescence, depending on the condition of abnormal epithelium.
Some authors use other systems like D-Light, which is manufactured by Karl Storz, Germany. 8 What makes it less suitable for this method of tumor detection is the use of correction of the observational techniques. It requires an endoscope of specifi c design that includes a fi lter wheel with two different positions for the white light mode and the autofl uorescence mode.
The Onco-LIFE system is used by P. Lee et al. 5 Onco-LIFE combines fl uorescence and refl ectance imaging with aims to reduce false-positive fl uorescence. It is due to increased vascularity frequently associated with airway infl ammation. The Onco-LIFE device allows composite quantifi cation of red refl ectance and green fl uorescence intensity signals by numerically expressing the red-to-green ratio (R/G ratio) of the area of interest.
Stringer MR et al. used the Xillix LIFE lung System. 19 AFB was fi rst developed at the British Columbia Cancer Research Centre (Vancouver, BC, Canada) and became commercially available in 1998. The original LIFE-Lung1 system used a helium-cadmium laser for illumination and detected the emitted red and green autofl uorescent light with two image-intensifi ed charge-coupled device (CCD) cameras. Normal areas appear green and abnormal areas appear reddish brown, owing to reduced green autofl uorescence in pre-neoplastic and neoplastic lesions.
All these systems demonstrate similar results, where AFB outperforms WLB, especially in the cases of diagnostic approach of premalignant endobronchial changes. 11, 12, 14 If a bronchoscopy unit has an equipment which allows it to perform AFB it is obvious that it can be used as a supplement in the course of routine WLB. Better visualisation of the epithelium and better targeting during biopsy procedures are signifi cant advantages. The disadvantages are the high price of the equipment and the low specifi city. [20] [21] [22] 
CONCLUSION
The results of this study confi rmed the fi ndings of other authors that AFB has better diagnostic value than WLB in diagnosing endobronchial carcinoma in situ, microinvasive carcinoma and invasive carcinoma together.
The acceptance of the suspected and malignant changes as a target and performing biopsy at this point, increase the sensitivity of both WLB and AFB.
The exclusion of malignant endobronchial disease is less possible, same as published by other authors.
AFB is comfortable, easy and effective method for diagnostic approach of endobronchial lung cancer when the equipment is available.
